Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
- PMID: 10597222
- DOI: 10.1038/sj.onc.1203031
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
Abstract
Hexamethylen-bisacetamide (HMBA) represents the prototype of a group of hybrid polar compounds, which induce differentiation in a variety of transformed cells including human embryonal carcinoma cells. Therefore, HMBA has been used in the differentiation therapy of cancer for patients with both hematological and solid malignancies. Upon HMBA treatment, the embryonal carcinoma cell line NTERA-2 clone D1 (NT2/D1) accumulates in G1 and undergoes terminal differentiation. Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4). When HMBA differentiation was induced in the presence of p27 antisense oligonucleotides, NT2/D1 cells failed to arrest growth properly and, in parallel with the reduction of the anti-apoptotic Bcl-2 gene expression, cells underwent massive programmed cell death. Conversely, constitutive expression of p27 into NT2/D1 cells induced a marked reduction in the growth potential of these cells and partially reproduced HMBA-induced modification of surface antigen expression (down-regulation of SSEA-3 expression and up-regulation of VINIS-53 expression). Expression of p21 induced growth arrest but not differentiation. Likewise, inhibition of CDK2 by transfection of a dominant negative CDK2 in NT2/D1 cells or treatment with the kinase inhibitor olomucine induced growth arrest but not differentiation. Therefore, we propose that p27 represents a crucial molecule in HMBA signaling that cannot be replaced by p21. Furthermore, the results obtained with CDK2 inhibitors demonstrate that the block of CDK2 activity is sufficient for growth arrest but not for cell differentiation and suggest that, at least in these cells, growth arrest and differentiation are regulated by two overlapping but different pathways.
Similar articles
-
Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.Blood. 2000 Oct 15;96(8):2746-54. Blood. 2000. PMID: 11023508
-
Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.J Cell Biochem. 1999 Oct 1;75(1):1-12. J Cell Biochem. 1999. PMID: 10462699
-
Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.Cancer Res. 1999 May 15;59(10):2318-23. Cancer Res. 1999. PMID: 10344736
-
Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.Leuk Lymphoma. 2000 Jul;38(3-4):235-46. doi: 10.3109/10428190009087015. Leuk Lymphoma. 2000. PMID: 10830731 Review.
-
[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].Cancer Radiother. 2001 Apr;5(2):109-29. doi: 10.1016/s1278-3218(01)00087-7. Cancer Radiother. 2001. PMID: 11355576 Review. French.
Cited by
-
Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells.Exp Hematol. 2008 Feb;36(2):128-39. doi: 10.1016/j.exphem.2007.09.004. Epub 2007 Nov 26. Exp Hematol. 2008. PMID: 18023519 Free PMC article.
-
Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.Cell Prolif. 2008 Dec;41(6):875-893. doi: 10.1111/j.1365-2184.2008.00556.x. Cell Prolif. 2008. PMID: 19040567 Free PMC article.
-
Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.Br J Cancer. 2005 Aug 8;93(3):338-45. doi: 10.1038/sj.bjc.6602709. Br J Cancer. 2005. PMID: 16012517 Free PMC article.
-
Immunohistochemical localization of mdm-2, p27Kip1 and bcl-2 in Warthin's tumor of the parotid gland.Diagn Pathol. 2009 May 16;4:14. doi: 10.1186/1746-1596-4-14. Diagn Pathol. 2009. PMID: 19445705 Free PMC article.
-
FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.Am J Pathol. 2002 Apr;160(4):1345-52. doi: 10.1016/S0002-9440(10)62561-8. Am J Pathol. 2002. PMID: 11943719 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
